Future Telos Robotic Platform
* Currently in development. Not approved for use or available for sale.
We’ve built technologies to reach the clot.
The next challenge is reaching the patient.
1 in 5
estimated to have received aspiration thrombectomy in 2024**
The lack of access to thrombectomy is a public health crisis
This problem cannot be solved by products alone. Expanding access requires new approaches to bringing lifesaving treatment to more patients, in more places.
The Telos Robotic Platform is being developed to expand access to lifesaving treatment.
We are developing the Telos platform with the goal of bringing greater precision and standardization to procedures and expanding access to lifesaving treatment.
* Currently in development. Not cleared, approved, or available for sale.
** For more information on our total addressable market opportunity, including the basis of our estimated, methodology, sources, and assumptions, see ‘Business - Market Opportunity - Ischemic Stroke Market - Ischemic Stroke and Neurointerventional Market Opportunity’ and ‘Business - Market Opportunity - Peripheral Vascular Market - Peripheral Industry Opportunity.’